US2014039285A1PendingUtilityA1

Glucose measurement device and methods using rfid

Assignee: ABBOTT DIABETES CARE INCPriority: Feb 8, 2005Filed: Oct 2, 2013Published: Feb 6, 2014
Est. expiryFeb 8, 2025(expired)· nominal 20-yr term from priority
A61B 2562/085A61B 2562/0295G01N 33/48771A61B 5/7282A61B 5/14503A61B 90/98A61B 5/1495G08C 17/02A61B 5/14532A61B 5/150358A61B 90/90A61B 5/14735A61B 5/7275A61B 2562/08A61B 5/0004A61B 5/1486A61B 5/1473G06K 7/10366A61B 5/0022A61B 5/0026A61B 5/742
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A glucose monitoring system, includes a glucose sensor strip or package of strips. The strip includes a substrate and a glucose monitoring circuit that has electrodes and a bodily fluid application portion of selected chemical composition. An antenna is integrated with the glucose sensor strip. An RFID sensor chip is coupled with the glucose sensor strip and the antenna. The chip has a memory containing digitally-encoded data representing calibration and/or expiration date information for the strip.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An analyte monitoring system for use in diabetes management, comprising:
 (a) a radio frequency identification (RFID) reader that is adapted to transmit a first radio wave and receive a second radio wave; and   (b) an analyte sensing device, comprising:
 a partially or fully implantable in vivo analyte sensor; and 
 an RFID sensor comprising a memory in which digitally encoded diabetes information of the partially or fully implantable in vivo analyte sensor can be stored, wherein the RFID sensor is adapted to receive the first radio wave from the RFID reader and, after receipt of the first radio wave, transmit the diabetes information in the second radio wave to the RFID reader, 
   wherein the RFID reader is adapted to read the diabetes information in the second radio wave received from the RFID sensor.   
     
     
         2 . The analyte monitoring system of  claim 1 , wherein the RFID sensor is a passive RFID sensor. 
     
     
         3 . The analyte monitoring system of  claim 2 , wherein the first radio wave is an interrogation signal and the second radio wave is a backscattered radio wave, and wherein the RFID sensor is adapted to transmit the second radio wave in response to impingement of the first radio wave on an antenna of the RFID sensor. 
     
     
         4 . The analyte monitoring system of  claim 2 , wherein the RFID sensor is adapted to use power from the first radio wave. 
     
     
         5 . The analyte monitoring system of  claim 2 , wherein the passive RFID sensor does not comprise a battery. 
     
     
         6 . The analyte monitoring system of  claim 1 , wherein the RFID sensor is an active RFID sensor. 
     
     
         7 . The analyte monitoring system of  claim 1 , wherein the RFID sensor is part of an RFID tag. 
     
     
         8 . The analyte monitoring system of  claim 1 , wherein the RFID sensor is a chip mounted on a PCB substrate. 
     
     
         9 . The analyte monitoring system of  claim 1 , wherein the RFID sensor comprises a transponder that is adapted to receive the first radio wave and transmit the second radio wave, containing the diabetes information, after receipt of the first radio wave. 
     
     
         10 . The analyte monitoring system of  claim 1 , wherein the diabetes information includes calibration information, expiration information, data representing a lot number, data representing a manufacture date, or data representing a sensor type. 
     
     
         11 . The analyte monitoring system of  claim 1 , wherein the analyte sensing device comprises an antenna. 
     
     
         12 . The analyte monitoring system of  claim 11 , wherein the antenna is a loop antenna. 
     
     
         13 . The analyte monitoring system of  claim 11 , wherein the antenna is a dipole antenna. 
     
     
         14 . The analyte monitoring system of  claim 11 , wherein the antenna is integrated with the in vivo analyte sensor. 
     
     
         15 . The analyte monitoring system of  claim 14 , wherein the in vivo analyte sensor comprises a substrate, and wherein the antenna comprises a conducting loop extending around substantially a perimeter of the substrate and has two ends coupled with the RFID sensor. 
     
     
         16 . The analyte monitoring system of  claim 1 , wherein the in vivo analyte sensor comprises a plurality of electrodes that include a working electrode and a counter electrode. 
     
     
         17 . The analyte monitoring system of  claim 16 , wherein the plurality of electrodes includes a reference electrode. 
     
     
         18 . The analyte monitoring system of  claim 16 , wherein the in vivo analyte sensor comprises an analyte monitoring circuit having the plurality of electrodes and a bodily fluid application portion. 
     
     
         19 . The analyte monitoring system of  claim 1 , wherein the analyte sensing device is configured to perform electrolysis on a bodily fluid. 
     
     
         20 . The analyte monitoring system of  claim 1 , wherein the RFID reader comprises a pump. 
     
     
         21 . The analyte monitoring system of  claim 1 , wherein the RFID reader comprises a housing with a display and one or more operational buttons. 
     
     
         22 . The analyte monitoring system of  claim 1 , wherein the RFID reader comprises a transceiver and an antenna. 
     
     
         23 . The analyte monitoring system of  claim 22 , wherein the RFID reader further comprises a directional coupler that couples the transceiver to the antenna. 
     
     
         24 . The analyte monitoring system of  claim 22 , wherein the transceiver and antenna of the RFID reader are adapted to supply power to the RFID sensor with the first radio wave. 
     
     
         25 . The analyte monitoring system of  claim 1 , wherein the RFID reader has processing capability and is adapted to read the diabetes information from the second radio wave and use the diabetes information to determine an analyte level of a bodily fluid. 
     
     
         26 . The analyte monitoring system of  claim 1 , wherein the RFID reader is adapted to transmit a third radio wave to the RFID sensor, the third radio wave including information to be written to the RFID sensor. 
     
     
         27 . The analyte monitoring system of  claim 1 , wherein the RFID reader is capable of programming the RFID sensor. 
     
     
         28 . The analyte monitoring system of  claim 1 , wherein the RFID reader further comprises an analyte meter and a test strip port. 
     
     
         29 . The analyte monitoring system of  claim 28 , further comprising circuitry for determining the analyte level of a bodily fluid sample on a test strip inserted into the port. 
     
     
         30 . The analyte monitoring system of  claim 1 , wherein the RFID reader is integrated with an analyte meter. 
     
     
         31 . The analyte monitoring system of  claim 1 , further comprising a modular analyte meter. 
     
     
         32 . The analyte monitoring system of  claim 1 , wherein the RFID reader is adapted to communicate data with an analyte meter by way of a cable, multi-pin connection, or wireless connection. 
     
     
         33 . The analyte monitoring system of  claim 1 , wherein the RFID reader shares processing capability with an analyte meter. 
     
     
         34 . The analyte monitoring system of  claim 1 , wherein the RFID reader shares memory with an analyte meter. 
     
     
         35 . The analyte monitoring system of  claim 1 , wherein the RFID reader is a component of another device. 
     
     
         36 . The analyte monitoring system of  claim 1 , wherein the analyte is glucose. 
     
     
         37 . The analyte monitoring system of  claim 1 , wherein the first radio wave is in a frequency band around 13.56 MHz. 
     
     
         38 . The analyte monitoring system of  claim 1 , wherein the first radio wave is in a frequency band around 2.45 GHz.

Join the waitlist — get patent alerts

Track US2014039285A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.